- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage III Lung Non-Small Cell Cancer AJCC v7 in Colombia
Total 589 results
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IV Fallopian Tube Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Primary Peritoneal Cancer AJCC v8 | Stage II Fallopian Tube Cancer AJCC v8 | Stage II Ovarian... and other conditionsUnited States, Canada, Korea, Republic of, Puerto Rico, Ireland
-
PfizerCompletedNon-small Cell Lung CancerUnited States, France, Canada
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Switzerland, Australia
-
SCRI Development Innovations, LLCGenentech, Inc.Completed
-
Xiuning LeM.D. Anderson Cancer Center; Eli Lilly and CompanyActive, not recruitingNon Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | EGFR Gene MutationUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NFE2L2 Gene Mutation | NRF2 MutationUnited States
-
Dartmouth-Hitchcock Medical CenterSanofi; Genentech, Inc.CompletedCarcinoma, Non-Small-Cell Lung | NSCLC | Non-small Cell Lung CancerUnited States
-
Calithera Biosciences, IncTerminatedNon-Small Cell Lung Cancer | Non-squamous Non-small-cell Lung Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | KEAP1 Gene Mutation | NRF2 Gene Mutation | NFE2L2 Gene MutationUnited States
-
GlaxoSmithKlineTerminated
-
Eli Lilly and CompanyARMO BioSciencesTerminatedNon Small Cell Lung CancerUnited States
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
Mirati Therapeutics Inc.RecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Colo-rectal CancerUnited States, Puerto Rico
-
AstraZenecaRecruitingNon-small Cell Lung CancerSpain, Italy, France, Canada, Portugal, United States, Czechia, Germany, Sweden, Austria, Hungary
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable MelanomaUnited States
-
Geron CorporationCompletedNon-small Cell Lung CancerUnited States, Canada, Germany
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
Immunotec Inc.TerminatedNON-SMALL CELL LUNG CANCERCanada
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Daiichi Sankyo, Inc.CompletedMetastatic Non-small Cell Lung CancerUnited States, India, Poland, Romania
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited States
-
Peregrine PharmaceuticalsCompletedNon-small-cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Verastem, Inc.AmgenRecruitingNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, United Kingdom, Netherlands, Belgium
-
Mark VincentAstraZenecaRecruitingNon-Small Cell Lung CancerCanada
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States
-
Canadian Cancer Trials GroupCancer Research Institute, New York City; Personal Genome Diagnostics (PGDx); Mark Foundation for Cancer ResearchRecruitingNon-Small Cell Lung CancerCanada, United States
-
AbbVieTerminated
-
Georgetown UniversityAstraZenecaRecruitingCarcinoma, Non-Small Cell LungUnited States
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Israel, Malaysia, Australia, Georgia, Turkey, Canada
-
Eli Lilly and CompanyCompletedAdvanced Non-Small Cell Lung CancerUnited States
-
Eisai Inc.CompletedNon-small Cell Lung CancerSpain, United States, Canada, Austria, France, Germany
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerUnited States, Spain, China, France, Canada, Italy
-
Eli Lilly and CompanyARMO BioSciencesTerminated
-
University of Colorado, DenverInivataWithdrawnNon-Small Cell Lung CancerUnited States
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France, United Kingdom
-
Eli Lilly and CompanyCompletedSquamous Non Small Cell Lung CancerUnited States, Germany, Poland, Mexico, Korea, Republic of, Russian Federation
-
National Cancer Institute, NaplesUniversity of Alberta; University of Campania "Luigi Vanvitelli"; Princess Margaret... and other collaboratorsCompletedAdvanced Non-Small Cell Lung CancerItaly, Canada
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Locally Advanced Rectal CarcinomaUnited States, Puerto Rico